All Articles

Polar Power's new trial with a major Asian telecom operator explores if LPG generators can solve diesel theft, cut emissions, and save its balance sheet.

Pickering Interfaces' new 65-217 modular LXI matrix tackles test system obsolescence, bringing scalable capacity and vital RF diagnostics to the assembly line.

Executives using AI solely for headcount reduction are starving their organizations of the upskilling needed to actually achieve productivity gains.

Invivyd's VYD2311 beats mRNA vaccines on tolerability and boosts immunity, but regulatory and economic hurdles loom large for the novel therapy.

With a $22.3 million NIH renewal, Florida's premier Alzheimer's consortium is pioneering non-invasive AI imaging, blending academic rigor with medtech agility.

Etruscus Resources’ latest financing reveals the high-stakes financial and geological maneuvering driving junior exploration in BC's Golden Triangle.

To unlock the true potential of AI in drug discovery, Big Pharma must first clean its messy data. Novartis just made a massive move to do exactly that.

From Gen Z's experiential spending to a one-way US-Canada border, FlightHub’s latest data reveals the macroeconomic forces reshaping global tourism.

As 90% of tested brands show links to prohibited cotton, Oritain's new 7-day forensic testing and API integration turns compliance into a competitive edge.

As dental laboratories drown in incompatible scanner files and emails, Relu's new Single Inbox offers a $250,000 lifeline by automating case intake entirely.

By trading toxic payloads for precise degradation, Nurix Therapeutics is writing a masterclass in biotech survival and post-merger pharmaceutical strategy.

U.S. domestic airfares surged nearly 50% in 2026, forcing a massive consumer shift as international flights became the new value play for American travelers.

As AI bandwidth demands push copper interconnects to their physical limits, Scintil Photonics brings in a manufacturing veteran to scale its laser technology.

Following its formation via private equity, Minaris reorganizes to tackle the viral vector capacity crunch and navigate the post-BIOSECURE Act landscape.

Despite massive hype, no dedicated AI tools cracked higher education's Top 100 enterprise apps. Strict compliance and security hurdles are keeping AI out.

A devastating E. coli outbreak exposes the gaps in a decades-old dairy rule, prompting a tactical legal push for mandatory raw milk cheese warning labels.

As Alfa Laval prepares to release its Q3 2026 earnings, market watchers are looking beyond the numbers to understand the pace of global marine decarbonization.

Vetsource launches a new high-tech pharmacy hub in Atlanta, intensifying the logistics battle against retail giants and empowering independent veterinarians.

Systemair's closure of its Waalwijk factory highlights a growing trend: European industrials are chasing margins by moving assembly while keeping local R&D.

Thorne’s latest consumer study claims massive cognitive and physical gains. But what does the data actually say about the mind-muscle connection?